
1. nat commun. 2017 mar 6;8:14574. doi: 10.1038/ncomms14574.

a potent antimalarial benzoxaborole targets plasmodium falciparum cleavage 
polyadenylation specificity factor homologue.

sonoiki e(1)(2), ng cl(3), lee mc(3), guo d(1), zhang yk(4), zhou y(4), alley
mr(4), ahyong v(5), sanz lm(6), lafuente-monasterio mj(6), dong c(4), schupp
pg(3), gut j(1), legac j(1), cooper ra(7), gamo fj(6), derisi j(5), freund yr(4),
fidock da(3)(8), rosenthal pj(1).

author information: 
(1)department medicine, university california, box 0811, san francisco,
california 94143, usa.
(2)division infectious diseases vaccinology, school public health,
university california, 293 university hall, 2199 addison street, berkeley,
california 94720-7360, usa.
(3)department microbiology immunology, columbia university medical center,
room 1502 hhsc, 701 west 168th street, new york, new york 10032, usa.
(4)anacor pharmaceuticals, inc., 1020 east meadow circle, palo alto, california
94303-4230, usa.
(5)department biochemistry biophysics, howard hughes medical institute,
university california, box 2542, 1700 4th street, 403c, san francisco,
california 94158, usa.
(6)malaria discovery performance unit, diseases developing world, tres
cantos medicines development campus,glaxosmithkline, c/severo ochoa 2, tres
cantos 28760, spain.
(7)department natural sciences mathematics, dominican university of
california, 50 acacia avenue, san rafael, california 94901, usa.
(8)division infectious diseases, department medicine, columbia university
medical center, new york, new york 10032, usa.

benzoxaboroles effective bacterial, fungal protozoan pathogens.
we report potent activity benzoxaborole an3661 plasmodium
falciparum laboratory-adapted strains (mean ic50 32 nm), ugandan field isolates
(mean ex vivo ic50 64 nm), murine p. berghei p. falciparum infections
(day 4 ed90 0.34 0.57 mg kg-1, respectively). multiple p. falciparum lines
selected vitro resistance an3661 harboured point mutations pfcpsf3, 
which encodes homologue mammalian cleavage polyadenylation specificity
factor subunit 3 (cpsf-73 cpsf3). crispr-cas9-mediated introduction pfcpsf3
mutations parental lines recapitulated an3661 resistance. pfcpsf3 homology
models placed mutations active site, an3661 predicted to
bind. transcripts three trophozoite-expressed genes lost in
an3661-treated trophozoites, observed parasites selected or
engineered an3661 resistance. results identify pre-mrna processing
factor pfcpsf3 promising antimalarial drug target.

doi: 10.1038/ncomms14574 
pmcid: pmc5343452
pmid: 28262680  [indexed medline]

